Cyberoptics Cp (CYBE) 21.11 $CYBE CyberOptics to Present

New Post Public Reply Private Reply Replies (0) Message Board

Sep 4, 2016 at 5:22 AM

Cyberoptics Cp (CYBE) 21.11 $CYBE

CyberOptics to Present at 5th Annual InvestMNt Conference August 23-24, 2016
BusinessWire - Wed Aug 10, 7:00AM CDT
CyberOptics(R) Corporation (NASDAQ: CYBE), a leading global developer and manufacturer of high precision 3D sensing technology solutions announced today that the Company will present at the 5th Annual 2016 InvestMNt Conference sponsored by CFA Society Minnesota.
CYBE: 21.11 (+0.53)

CyberOptics Reports Strong Second Quarter Year-Over-Year Sales and Earnings Growth
BusinessWire - Thu Jul 28, 3:00PM CDT
CyberOptics Corporation (Nasdaq: CYBE) today reported operating results for the second quarter of 2016 ended June 30.
NDSN: 100.57 (+1.38), CYBE: 21.11 (+0.53)

Cyberoptics Has Returned 97.0% Since SmarTrend Recommendation (CYBE)
Comtex SmarTrend(R) - Thu Jun 02, 12:38PM CDT
SmarTrend identified an Uptrend for Cyberoptics (NASDAQ:CYBE) on January 8th, 2016 at $8.33. In approximately 5 months, Cyberoptics has returned 97.00% as of today's recent price of $16.40.
CYBE: 21.11 (+0.53)

86.8% Return Seen to Date on SmarTrend Cyberoptics Call (CYBE)
Comtex SmarTrend(R) - Thu May 19, 12:09AM CDT
SmarTrend identified an Uptrend for Cyberoptics (NASDAQ:CYBE) on January 8th, 2016 at $8.33. In approximately 4 months, Cyberoptics has returned 86.79% as of today's recent price of $15.55.
CYBE: 21.11 (+0.53)

Cyberoptics Shares Up 102.0% Since SmarTrend's Buy Recommendation (CYBE)
Comtex SmarTrend(R) - Wed May 11, 12:38PM CDT
SmarTrend identified an Uptrend for Cyberoptics (NASDAQ:CYBE) on January 8th, 2016 at $8.33. In approximately 4 months, Cyberoptics has returned 102.04% as of today's recent price of $16.82.
CYBE: 21.11 (+0.53)

Q1 Earnings Reports in Full-on Squall: WYNN, SQ, YELP, FEYE, CYBR
Mark Vickery - Zacks Investment Research - Thu May 05, 5:17PM CDT
Late Q1 earnings Thursday include Wynn(WYNN), Square (SQ), Yelp! (YELP), FireEye (FEYE) and CyberArk (CYBR).
FEYE: 15.23 (+0.04), WYNN: 92.38 (-0.79), YELP: 38.78 (-0.11), CYBE: 21.11 (+0.53), SQ: 12.05 (+0.05)

Four Top Stocks: Investors Are Considering These on Friday April 29th
ACCESSWIRE - Fri Apr 29, 12:26PM CDT
MIAMI, FL / ACCESSWIRE / April 29, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. EHTH, CYBE, COOL, and PRGN have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
PRGN: 0.73 (-0.03), COOL: 3.70 (-0.05), CYBE: 21.11 (+0.53), EHTH: 11.51 (+0.19)

CyberOptics Reports Strong First Quarter Sales Growth and Earnings
BusinessWire - Thu Apr 28, 3:00PM CDT
CyberOptics Corporation (Nasdaq: CYBE) today reported operating results for the first quarter of 2016 ended March 31.
NDSN: 100.57 (+1.38), KLAC: 70.20 (-0.54), CYBE: 21.11 (+0.53)

CyberOptics First Quarter 2016 Conference Call Scheduled for April 28
BusinessWire - Tue Apr 26, 9:21AM CDT
CyberOptics Corporation (Nasdaq:CYBE) will hold a conference call to review its operating results for the first quarter of 2016 on Thursday, April 28 at 4:30 PM Eastern. The first quarter earnings release will be issued at the close of the market that day.
CYBE: 21.11 (+0.53)

Cyberoptics Up 71.4% Since SmarTrend Uptrend Call (CYBE)
Comtex SmarTrend(R) - Fri Apr 22, 12:08AM CDT
SmarTrend identified an Uptrend for Cyberoptics (NASDAQ:CYBE) on January 8th, 2016 at $8.33. In approximately 3 months, Cyberoptics has returned 71.41% as of today's recent price of $14.27.
CYBE: 21.11 (+0.53)

Uptrend Call Working As Cyberoptics Stock Rises 40.5% (CYBE)
Comtex SmarTrend(R) - Thu Apr 14, 1:07PM CDT
SmarTrend identified an Uptrend for Cyberoptics (NASDAQ:CYBE) on January 8th, 2016 at $8.33. In approximately 3 months, Cyberoptics has returned 40.54% as of today's recent price of $11.70.
CYBE: 21.11 (+0.53)

CyberOptics Forecasts Revenues of $18.6-$19.1 Million for First Quarter of 2016
BusinessWire - Tue Apr 12, 3:00PM CDT
CyberOptics Corporation (Nasdaq: CYBE) today reported that it is forecasting revenues of $18.6-$19.1 million and strong profitability for the first quarter of 2016 ended March 31, compared to revenues of $9.5 million in the first quarter of 2015.
CYBE: 21.11 (+0.53)

CyberOptics Presents Solution for Monitoring Relative Humidity (RH) in Real-Time to Improve Yield and Reduce Downtime
BusinessWire - Tue Mar 29, 6:00PM CDT
CyberOptics(R) Corporation (NASDAQ: CYBE), a leading global developer and manufacturer of high precision 3D sensing technology solutions, will present and exhibit at The 23rd Symposium on Photomask and NGL Mask Technology in Yokohama, Japan, 6-8 April 2016.
CYBE: 21.11 (+0.53)

CyberOptics to Display APS2 Technology at SEMICON Korea
BusinessWire - Tue Jan 19, 6:00AM CST
CyberOptics(R) Corporation (NASDAQ:CYBE), a leading global developer and manufacturer of high precision 3D sensing technology solutions, will showcase the WaferSense(R) and ReticleSense(R) Airborne Particle Sensor (APS2) technology at SEMICON Korea, the largest microelectronics event in Korea, January 27-29, 2016, at the Winix booth (Hole A #2228)
CYBE: 21.11 (+0.53)

CyberOptics Announces $2.0 Million Follow-On Order for 3D AOI Systems
BusinessWire - Fri Jan 08, 8:00AM CST
CyberOptics Corporation (Nasdaq: CYBE) today announced an order valued at approximately $2.0 million for SQ3000 automated optical inspection (AOI) systems, based upon the company's 3D MRS inspection technology platform. Scheduled for shipment in the first quarter of 2016, this order follows a previously reported $750,000 order for SQ3000 systems that shipped in the fourth quarter of 2015.
CYBE: 21.11 (+0.53)

CyberOptics Receives $800,000 Order for 3D MRS Sensors
BusinessWire - Tue Jan 05, 3:00PM CST
CyberOptics Corporation (Nasdaq: CYBE) today announced that it has received an order from a key OEM customer valued at approximately $800,000 for 3D MRS-enabled sensor subsystems. This order is currently scheduled to ship in the first quarter of 2016.
CYBE: 21.11 (+0.53)

CyberOptics Receives $750,000 Order For SQ3000 3D AOI Systems
BusinessWire - Tue Nov 17, 8:00AM CST
CyberOptics Corporation (Nasdaq:CYBE) today announced that it received a follow-on order valued at approximately $750,000 for SQ3000 automated optical inspection systems, based upon the company's 3D Multi-Reflection Suppression (MRS) inspection technology platform. This 3D AOI order is scheduled to ship in this year's fourth quarter.
CYBE: 21.11 (+0.53)

CyberOptics Wins Its Third Award for the New SQ3000 3D AOI
BusinessWire - Wed Nov 11, 3:00AM CST
CyberOptics(R) Corporation (NASDAQ:CYBE) announces that it was awarded a 2015 Global Technology Award in the category of Inspection - AOI for its SQ3000(TM) 3D Automated Optical Inspection (AOI) system. The award was presented to the company during a Tuesday, Nov. 10, 2015, ceremony that took place at the Messe Munchen exhibition center in Munich, Germany during productronica, the world's leading trade fair for electronics development and production. This marks the third award for the SQ3000 3D AOI since its introduction this year.
CYBE: 21.11 (+0.53)

CyberOptics Receives $1.1 Million Order for 3D MRS Sensors
BusinessWire - Mon Nov 09, 7:00AM CST
CyberOptics Corporation (Nasdaq: CYBE) today announced that it has received an order valued at approximately $1.1 million for 3D MRS-enabled sensor subsystems from a key OEM customer. Shipments under this order are expected to commence late in 2015 and continue into the first quarter of 2016.
CYBE: 21.11 (+0.53)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Luvme Hair Offers Wig Variety for Winter Fashion

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...